Management of Ivabradine-Induced Tremors

Adverse Effects and Interactions

Phosphenes (visual brightness phenomena) occur in 3-15% of patients taking ivabradine, typically transient and rarely requiring discontinuation, according to the American College of Cardiology 1, 2, 3, 4, 5
Concurrent medications, such as beta-blockers, can cause tremor, particularly at higher doses, as noted by the American College of Cardiology 1, 4, 5
Metabolic derangements, including thyroid dysfunction, electrolyte abnormalities, and hypoglycemia, can contribute to tremor, as reported by Praxis Medical Insights 6
Neurological conditions, such as essential tremor, Parkinson's disease, or other movement disorders, should be considered in the differential diagnosis, according to Praxis Medical Insights 6

When tremors develop in a patient on ivabradine, the American College of Cardiology recommends verifying the adverse effect attribution and assessing for other medications or conditions that commonly cause tremor 5
If tremor persists and other causes are excluded, the American College of Cardiology suggests considering medication adjustment, such as reducing the ivabradine dose or switching to monotherapy, if beta-blocker side effects are suspected 1, 4, 5
The American College of Cardiology advises against automatically discontinuing ivabradine for tremor without investigating other causes, as this side effect is not established in the literature 5
Regular monitoring requirements include assessing heart rate, cardiac rhythm, and screening for drug interactions, especially strong CYP3A4 inhibitors, which are contraindicated, as recommended by the American College of Cardiology 1, 4, 5